These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29368865)

  • 21. Pretreatment with 5-Fluorouracil Cream Enhances the Efficacy of Daylight-mediated Photodynamic Therapy for Actinic Keratosis.
    Nissen CV; Heerfordt IM; Wiegell SR; Mikkelsen CS; Wulf HC
    Acta Derm Venereol; 2017 May; 97(5):617-621. PubMed ID: 28093604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conventional vs. daylight photodynamic therapy for patients with actinic keratosis on face and scalp: 12-month follow-up results of a randomized, intra-individual comparative analysis.
    Sotiriou E; Evangelou G; Papadavid E; Apalla Z; Vrani F; Vakirlis E; Panagiotou M; Stefanidou M; Pombou T; Krasagakis K; Rigopoulos D; Ioannides D
    J Eur Acad Dermatol Venereol; 2018 Apr; 32(4):595-600. PubMed ID: 28972663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Home- vs clinic-based daylight photodynamic therapy with 5-aminolevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis: A randomized, single-blind, prospective study.
    Saenz-Guirado S; Ayen-Rodriguez A; Galvez-Moreno M; Velasco-Amador JP; Llamas-Molina JM; Ruiz-Villaverde R; Molina-Leyva A
    Photodiagnosis Photodyn Ther; 2024 Apr; 46():104031. PubMed ID: 38438001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Daylight photodynamic therapy vs. Conventional photodynamic therapy as skin cancer preventive treatment in patients with face and scalp cancerization: an intra-individual comparison study.
    Sotiriou E; Apalla Z; Vrani F; Lazaridou E; Vakirlis E; Lallas A; Ioannides D
    J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):1303-1307. PubMed ID: 28222225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Daylight photodynamic therapy versus cryosurgery for the treatment and prophylaxis of actinic keratoses of the face - protocol of a multicenter, prospective, randomized, controlled, two-armed study.
    Kohl E; Koller M; Zeman F; Szeimies RM; Philipp-Dormston WG; Prager W; Gerber PA; Karrer S
    BMC Dermatol; 2017 Oct; 17(1):12. PubMed ID: 29070025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Daylight photodynamic therapy of actinic keratosis without curettage is as effective as with curettage: a randomized clinical trial.
    Heerfordt IM; Wulf HC
    J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):2058-2061. PubMed ID: 31197894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia.
    See JA; Shumack S; Murrell DF; Rubel DM; Fernández-Peñas P; Salmon R; Hewitt D; Foley P; Spelman L
    Australas J Dermatol; 2016 Aug; 57(3):167-74. PubMed ID: 26033230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daylight photodynamic therapy with methyl aminolevulinate cream is as effective as conventional photodynamic therapy with blue light in the treatment of actinic keratosis: a controlled randomized intra-individual study.
    Assikar S; Labrunie A; Kerob D; Couraud A; Bédane C
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1730-1735. PubMed ID: 31955461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of clinical and histologic findings in daylight photodynamic therapy for skin field cancerization: A randomized controlled four-arm study on physical methods-assisted delivery of methyl aminolevulinate.
    Bento CO; Pantaleão L; de Souza MB; Vilar EAG; Luiz RR; Filho PJS; Gismondi RAOC; Issa MCA
    Photodiagnosis Photodyn Ther; 2021 Sep; 35():102404. PubMed ID: 34133958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methyl aminolevulinate daylight photodynamic therapy applied at home for non-hyperkeratotic actinic keratosis of the face or scalp: an open, interventional study conducted in Germany.
    Karrer S; Aschoff RAG; Dominicus R; Krähn-Senftleben G; Gauglitz GG; Zarzour A; Kerrouche N; Chavda R; Szeimies RM
    J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):661-666. PubMed ID: 30633376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-aminolaevulinic acid nanoemulsion is more effective than methyl-5-aminolaevulinate in daylight photodynamic therapy for actinic keratosis: a nonsponsored randomized double-blind multicentre trial.
    Räsänen JE; Neittaanmäki N; Ylitalo L; Hagman J; Rissanen P; Ylianttila L; Salmivuori M; Snellman E; Grönroos M
    Br J Dermatol; 2019 Aug; 181(2):265-274. PubMed ID: 30329163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized split-scalp study comparing calcipotriol-assisted methyl aminolaevulinate photodynamic therapy (MAL-PDT) with conventional MAL-PDT for the treatment of actinic keratosis.
    Torezan L; Grinblat B; Haedersdal M; Valente N; Festa-Neto C; Szeimies RM
    Br J Dermatol; 2018 Oct; 179(4):829-835. PubMed ID: 29476546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conventional versus daylight photodynamic therapy for actinic keratosis: A randomized and prospective study in China.
    Zhu L; Wang P; Zhang G; Zhang L; Liu X; Hu C; Yang X; Sroka R; Zhou Z; Wang X
    Photodiagnosis Photodyn Ther; 2018 Dec; 24():366-371. PubMed ID: 30336290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical efficacy of topical methyl-aminolevulinate photodynamic therapy in moderate to severe actinic keratoses of the face and scalp.
    Kleinpenning MM; van de Kerkhof PC; Gerritsen RM
    J Dermatolog Treat; 2010 Jul; 21(4):252-7. PubMed ID: 19832288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The conventional protocol vs. a protocol including illumination with a fabric-based biophotonic device (the Phosistos protocol) in photodynamic therapy for actinic keratosis: a randomized, controlled, noninferiority clinical study.
    Mordon S; Vignion-Dewalle AS; Abi-Rached H; Thecua E; Lecomte F; Vicentini C; Deleporte P; Béhal H; Kerob D; Hommel T; Duhamel A; Szeimies RM; Mortier L
    Br J Dermatol; 2020 Jan; 182(1):76-84. PubMed ID: 31021404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Daylight-mediated photodynamic therapy for actinic damage in Latin America: consensus recommendations.
    Grinblat B; Galimberti G; Chouela E; Sanclemente G; Lopez M; Alcala D; Torezan L; Pantoja G
    Photodermatol Photoimmunol Photomed; 2016 Mar; 32(2):81-7. PubMed ID: 26541910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Keratolytics can replace curettage in daylight photodynamic therapy for actinic keratosis on the face/scalp: A randomized clinical trial.
    Caccavale S; Boccellino MP; Brancaccio G; Alfano R; Argenziano G
    J Eur Acad Dermatol Venereol; 2024 Mar; 38(3):594-601. PubMed ID: 38071596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of 5-Aminolevulinic Acid and Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses.
    Shive ML; Coakley BJ; Bierman DF; Serowka Lane KL; Wiegell SR; Haedersdal M; Zachary CB
    Dermatol Surg; 2019 Apr; 45(4):529-535. PubMed ID: 30807390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined daylight and conventional photodynamic therapy with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis of the face and scalp: a new and efficient approach.
    Salido-Vallejo R; Jiménez-Nájar F; Garnacho-Sucedo G; Vélez A
    Arch Dermatol Res; 2020 Nov; 312(9):675-680. PubMed ID: 31838569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Daylight-Mediated Photodynamic Therapy With Methyl Aminolevulinate in Actinic Keratosis Treatment.
    Demay SDJ; Sharma K; Sapra S; Sapra R; Sapra P
    J Cutan Med Surg; 2018; 22(3):267-272. PubMed ID: 29351725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.